PTC Therapeutics
PTCT
#3260
Rank
โ‚ฌ3.44 B
Marketcap
44,61ย โ‚ฌ
Share price
2.19%
Change (1 day)
72.77%
Change (1 year)

Revenue for PTC Therapeutics (PTCT)

Revenue in 2024 (TTM): โ‚ฌ0.82 Billion

According to PTC Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.86 Billion. In 2023 the company made a revenue of โ‚ฌ0.84 Billion an increase over the revenue in the year 2022 that were of โ‚ฌ0.65 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for PTC Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.82 B-3.03%
2023 โ‚ฌ0.84 B30.22%
2022 โ‚ฌ0.65 B36.98%
2021 โ‚ฌ0.47 B53.63%
2020 โ‚ฌ0.30 B12.97%
2019 โ‚ฌ0.27 B18.42%
2018 โ‚ฌ0.23 B42.84%
2017 โ‚ฌ0.16 B106.05%
2016 โ‚ฌ78.62 M119.04%
2015 โ‚ฌ35.89 M90.11%
2014 โ‚ฌ18.88 M-16.76%
2013 โ‚ฌ22.68 M4.26%
2012 โ‚ฌ21.75 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ10.25 B 1,079.77%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.58 B 82.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ12.97 M-98.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.76 M-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ82.16 M-90.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ48.18 B 5,444.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland